Evidence map›Paper›PMID 26745724›Full record

ArticlePloS one2016

Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages.

Cecile Herate, Ghania Ramdani, Nancy J Grant, Sabrina Marion, Stephane Gasman, Florence Niedergang, Serge Benichou, Jerome Bouchet

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Identifying key genes in CD4Frontiers in genetics · 2022
    Article
  15. Article
  16. Two gene set variation indexes as potential diagnostic tool for sepsis.American journal of translational research · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Cecile HerateInserm U1016, Institut Cochin, Paris, France.
Ghania RamdaniInserm U1016, Institut Cochin, Paris, France.
Nancy J GrantInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR3212, and Université de Strasbourg, Strasbourg, France.
Sabrina MarionInserm U1016, Institut Cochin, Paris, France.
Stephane GasmanInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR3212, and Université de Strasbourg, Strasbourg, France.
Florence NiedergangInserm U1016, Institut Cochin, Paris, France.
Serge BenichouInserm U1016, Institut Cochin, Paris, France.
Jerome BouchetInserm U1016, Institut Cochin, Paris, France.
Centre National de la Recherche Scientifique · FRInserm · FRDélégation Paris 5 · FRInstitut Cochin · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phospholipid Scramblase 1 (PLSCR1) was initially characterized as a type II transmembrane protein involved in bilayer movements of phospholipids across the plasma membrane leading to the cell surface exposure of phosphatidylserine, but other cellular functions have been ascribed to this protein in signaling processes and in the nucleus. In the present study, expression and functions of PLSCR1 were explored in specialized phagocytic cells of the monocyte/macrophage lineage. The expression of PLSCR1 was found to be markedly increased in monocyte-derived macrophages compared to undifferentiated primary monocytes. Surprisingly, this 3-fold increase in PLSCR1 expression correlated with an apparent modification in the membrane topology of the protein at the cell surface of differentiated macrophages. While depletion of PLSCR1 in the monocytic THP-1 cell-line with specific shRNA did not inhibit the constitutive cell surface exposure of phosphatidylserine observed in differentiated macrophages, a net increase in the FcR-mediated phagocytic activity was measured in PLSCR1-depleted THP-1 cells and in bone marrow-derived macrophages from PLSCR1 knock-out mice. Reciprocally, phagocytosis was down-regulated in cells overexpressing PLSCR1. Since endogenous PLSCR1 was recruited both in phagocytic cups and in phagosomes, our results reveal a specific role for induced PLSCR1 expression in the modulation of the phagocytic process in differentiated macrophages.

Indexed as

AnimalsBone Marrow CellsCell DifferentiationCell MembraneCells, CulturedDown-RegulationHeLa CellsHumansMacrophagesMiceMice, KnockoutMicroscopy, FluorescenceMonocytesPhagocytosisPhosphatidylserinesPhospholipid Transfer ProteinsPhosphatidylserinesPhospholipid Transfer ProteinsPlscr1 protein, mouseReceptors, FcRNA, Small Interfering

Identifiers

PMID26745724
PMCPMC4712888
OpenAlexW2230542237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.